Pathnostics - A Diagnostics Solutions Company

Pathnostics is a leading precision diagnostic testing and development company focused on improving patient care and empowering physicians. Established in 2011 in Irvine, California, the company pioneers innovative approaches in infectious disease and cancer diagnostics. Their flagship product, the advanced Guidance® UTI diagnostic test, utilizes PCR testing and proprietary Pooled Antibiotic Susceptibility Testing™ (P-AST™) to provide more informed treatment decisions in less than a day. Pathnostics emphasizes personalized therapy and antibiotic stewardship to better address polymicrobial infections, especially in complicated, recurrent, or persistent UTI cases. In February 2019, Pathnostics received a Private Equity Round investment from Water Street Healthcare Partners. The company's commitment to providing expert treatment options and empowering physicians aligns with current trends in the healthcare and biotechnology industries. This investment signifies growing interest in innovative diagnostics solutions that contribute to better patient outcomes and antibiotic stewardship. With its headquarters in the United States, Pathnostics is positioned to further advance its impact on patient care and diagnostics within the healthcare sector.